Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

ICAD stock price, quote, forecast and news

ICAD
US44934S2068
A1J20J

Price

1.42
Today +/-
-0.08
Today %
-6.14 %
P

ICAD stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the ICAD stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the ICAD stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the ICAD stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze ICAD's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

ICAD Stock Price History

DateICAD Price
9/6/20241.42 undefined
9/5/20241.51 undefined
9/4/20241.51 undefined
9/3/20241.53 undefined
8/30/20241.61 undefined
8/29/20241.56 undefined
8/28/20241.55 undefined
8/27/20241.57 undefined
8/26/20241.60 undefined
8/23/20241.70 undefined
8/22/20241.71 undefined
8/21/20241.70 undefined
8/20/20241.64 undefined
8/19/20241.74 undefined
8/16/20241.68 undefined
8/15/20241.49 undefined
8/14/20241.40 undefined
8/13/20241.36 undefined
8/12/20241.34 undefined

ICAD Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into ICAD, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by ICAD from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects ICAD’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of ICAD. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into ICAD’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing ICAD’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on ICAD’s growth potential.

ICAD Revenue, EBIT and net profit per share

DateICAD RevenueICAD EBITICAD Net Income
2026e29.59 M undefined-2.69 M undefined-2.57 M undefined
2025e24.35 M undefined-5.82 M undefined-5.82 M undefined
2024e19.6 M undefined-7.3 M undefined-7.31 M undefined
202317.32 M undefined-7.69 M undefined-4.85 M undefined
202227.94 M undefined-13.93 M undefined-13.66 M undefined
202133.64 M undefined-10.73 M undefined-11.25 M undefined
202029.7 M undefined-9.39 M undefined-17.61 M undefined
201931.34 M undefined-6.4 M undefined-13.55 M undefined
201825.62 M undefined-8.13 M undefined-9.02 M undefined
201728.1 M undefined-9.98 M undefined-14.26 M undefined
201626.34 M undefined-9.97 M undefined-10.1 M undefined
201541.55 M undefined-2.63 M undefined-32.45 M undefined
201443.92 M undefined810,000 undefined-1.01 M undefined
201333.07 M undefined-1.78 M undefined-7.61 M undefined
201228.28 M undefined-5.41 M undefined-9.37 M undefined
201128.65 M undefined-14.45 M undefined-37.59 M undefined
201024.58 M undefined-6.54 M undefined-6.22 M undefined
200928.11 M undefined-2.12 M undefined-1.97 M undefined
200837.49 M undefined4.77 M undefined4.36 M undefined
200726.61 M undefined-1.11 M undefined-1.61 M undefined
200619.72 M undefined-6.44 M undefined-6.75 M undefined
200519.77 M undefined-4.75 M undefined-4.88 M undefined
200423.31 M undefined-270,000 undefined-960,000 undefined

ICAD Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
19841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
000211182111232024201175674562319192637282428283343412628253129332717192429
----450.0063.6416.67-47.62109.09-13.0420.00-16.67-45.00-36.36-28.5720.0016.67-42.8625.0020.00283.33-17.39-36.8442.31-24.32-14.2916.67-17.8630.30-4.65-36.597.69-10.7124.00-6.4513.79-18.18-37.0411.7626.3220.83
----9.0922.2233.3336.3647.8335.0037.5030.009.0914.2920.0016.6714.29--50.0069.5778.9578.9580.7783.7875.0079.1771.4371.4369.7072.0970.7369.2364.2976.0077.4272.4172.7370.3782.35---
0000147411796111110031615152131211920202331291818192421241914000
-1-2-4-4-4-3-1-44-11-2-5-3-2-2-1-2-6-80-4-6-14-2-6-14-5-10-2-9-9-8-6-9-10-13-7-7-5-2
----200.00-36.36-16.67-4.76-36.3617.39-5.004.17-10.00-45.45-42.86-40.00-33.33-14.29-50.00-120.00-133.33--21.05-31.58-3.8510.81-7.14-25.00-50.00-17.86-3.03--4.88-34.62-32.14-32.00-19.35-31.03-30.30-48.15-41.18-36.84-20.83-6.90
-1-2-4-8-5-3-2-5300-5-60-3-4-2-2-9-80-4-6-14-1-6-37-9-7-1-32-10-14-9-13-17-11-13-4-7-5-2
-100.00100.00100.00-37.50-40.00-33.33150.00-160.00---20.00--33.33-50.00-350.00-11.11--50.00-83.33-500.00-125.00500.00516.67-75.68-22.22-85.713,100.00-68.7540.00-35.7144.4430.77-35.2918.18-69.2375.00-28.57-60.00
0.670.970.991.051.191.381.511.511.551.571.591.591.61.812.032.532.672.794.195.396.817.337.387.678.559.19.1710.9110.810.8414.115.6915.9316.3416.6918.3822.1424.7825.225.61000
-------------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The ICAD Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the ICAD is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (k)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
1984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                                               
5.413.425.480.13.085.140.440.380.251.760.650.580.240.240.180.261.450.51.095.18.014.613.624.3513.1216.2516.274.5813.9511.8832.2215.288.599.3912.1915.3127.1934.2821.3121.67
000.040.612.163.747.184.097.094.4886.473.471.481.571.41.080.691.553.345.013.963.686.485.574.693.3944.987.629.647.495.198.66.429.8310.5110.799.666.39
0001.180.10.120000000000000000000000000000000000
000.052.195.68.410.436.968.317.287.866.845.763.522.932.652.442.360.392.121.012.523.031.81.451.093.492.042.121.892.214.323.732.121.592.613.144.175.390.92
00.070.040.162.60.450.540.510.330.310.380.250.230.110.120.140.110.040.090.550.260.180.220.320.450.391.860.490.490.650.540.682.431.11.031.441.461.071.880.7
5.413.495.614.2413.5417.8518.5911.9415.9813.8316.8914.149.75.354.84.455.083.593.1211.1114.2911.2710.5512.9520.5922.4225.0111.1121.5422.0444.6127.7719.9421.2121.2329.1942.350.3138.2429.68
0.380.671.131.292.352.292.181.912.823.23.283.032.051.040.850.720.490.330.291.271.311.792.11.871.50.922.781.881.481.674.262.311.390.580.552.962.51.944.442.28
0000000000000000000000000000000000000000
0000000000000000000000000000000000001.430.840.020.16
000000000001.210.950.620.650.490.360.245.257.076.024.974.053.337.536.4821.1717.0615.2313.6717.54.273.181.931.551.180.890.680.480.15
00000000000000000017.4243.2143.5243.5243.5243.5243.5243.5245.9721.1121.1121.1127.2614.214.18.368.368.368.368.368.368.36
0.030.071.233.4832.981.121.220.81.081.40.120.10.080.060.040.02000000.060.060.060.060.680.60.640.420.130.090.050.050.050.050.090.060.170.79
0.410.742.364.775.355.273.33.133.624.284.684.363.11.741.561.250.870.5722.9651.5550.8550.2849.7348.7852.6150.9870.640.6538.4636.8749.1520.8718.7210.9210.5112.5513.2711.8813.4711.74
5.824.237.979.0118.8923.1221.8915.0719.618.1121.5718.512.87.096.365.75.954.1626.0862.6665.1461.5560.2861.7373.273.495.6151.766058.9193.7648.6438.6632.1331.7441.7455.5762.1951.7141.42
                                                                               
5050505070808080808080809090110130140150260340360370370390450460540110110110160160160170170200240250250265
6.487.517.5113.531.1641.9642.1442.2442.9943.5543.7643.9745.6245.6747.9452.5655.3757.1185.83120.4130.27130.78132.66135.06148.08150.06163.1164.43165.42166.74209.1211.51213.9217.39218.91230.62273.64300.86302.9306.25
-1.32-3.89-8.46-17.07-22.33-25.81-28.14-33.17-29.4-30.19-29.31-34.56-40.62-41.46-44.83-48.83-51.65-54.27-63.69-71.89-72.72-77.47-84.11-85.65-81.29-83.26-89.49-127.07-136.45-144.05-145.06-177.51-187.61-201.87-210.77-224.33-241.94-253.18-266.84-271.68
0000000000000000000000000000000000000000
0000000000000000000000000000000000000000
5.213.67-0.9-3.528.916.2314.089.1513.6713.4414.539.495.094.33.223.863.862.9922.448.8557.9153.6848.9249.867.2467.2674.1537.4729.0822.864.234.1626.4515.698.316.4931.9447.9336.3134.83
0.170.120.381.80.462.253.281.42.291.793.993.51.971.21.091.181.11.032.233.982.014.252.562.012.191.372.51.21.9422.151.591.581.361.151.992.872.781.970.71
0.050.050.091.490.350.550.370.330.350.680.830.711.030.340.350.340.430.412.012.322.041.922.773.462.752.125.525.524.644.285.694.184.994.44.977.347.776.535.262.64
00003.571.871.960.99000000000000.220.440.50.791.671.893.225.295.778.0612.299.177.546.215.485.265.256.125.656.223.4
0082.352.212.22.182.182.182.182.182.182.182.181.880.120.120.010.010.0100000000000000000000
000000000000000.770.50.50.560.071.231.51.50.383.48000003.885.040.970.090.831.874.260000
0.220.178.475.646.596.877.794.94.824.6576.395.183.724.092.142.152.014.327.765.998.176.510.626.836.7113.3112.4914.6422.4522.0514.2812.8712.0713.2518.8416.7614.9613.456.75
0.40.40.43.8721122.1113.583.48000.640.90.120.317.012.180.635.712.26000014.8512.016.620.0905.1511.2415.656.96000
00000000000000000000000000000000101000010106
00032.37000000000000000000.1200.070.49.083.222.843.082.321.530.750.630.362.191.340.713.351.25
0.40.40.46.874.371122.1113.583.48000.640.90.120.317.012.180.635.832.260.070.49.083.2217.6915.098.941.620.765.7911.617.848.30.723.361.25
0.620.578.8712.5110.967.878.796.96.925.6589.978.663.724.092.783.052.134.6314.778.178.812.3312.886.97.1122.3915.7132.3337.5430.9915.913.6317.8624.8536.6825.0615.6816.818
5.834.247.978.9919.8624.122.8716.0520.5919.0922.5319.4613.758.027.316.646.915.1227.0363.6266.0862.4861.2562.6874.1474.3796.5453.1861.4160.3495.1950.0640.0833.5533.1643.175763.6153.1242.83
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of ICAD provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand ICAD's financial health and stability.

Assets

ICAD's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that ICAD must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of ICAD after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into ICAD's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
-4-8-5-3-2-5300-5-60-3-4-1-2-9-80-4-6-14-1-6-37-9-7-1-32-10-14-9-13-17-11-13
0001201111210000001111111322332100000
0000000000000000000000000000000000000
0-1-3-4-53-40-1-120000030-210011300-1-1-50-32-20-2-2
0000100303030100320011111243423229181033
0000000000000000000000000012100000000
0000000000000000000000000000000000000
-4-10-7-6-40040-104-200-1-2-4-1-1-40930-10-4-13-1-5-7-3-7-6-9-12
-10-1-1-10-1-2-1-1000000000-1-10000000-100000000
-10-3-100-1-2-1-10000002-10-1-10-200000-4-20200000
00-201000000000002-10000-200000-3-10200000
0000000000000000000000000000000000000
83-1-2110-1020-3110000-4-1400000140-8-1205600-70
0115100000001010100690011000003000001019240
841481100021-321200105-140100-114021-120561019170
0000000000000000030000000-100000000000
0000000000000000000000000000000000000
2-520-3001-10000010042-300830-119-220-16-6023117-12
-5.94-10.61-9.07-8.37-5.87-1.06-1.092.17-1.32-2.86-1.93.43-2.52-1.29-0.82-1.58-2.41-5.03-2.3-2.36-5.59-0.149.163.13-0.14-10.42-4.94-2.141.94-2.87-5.83-7.74-4.19-7.42-7.46-10-13.32
0000000000000000000000000000000000000

ICAD stock margins

The ICAD margin analysis displays the gross margin, EBIT margin, as well as the profit margin of ICAD. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for ICAD.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the ICAD's sales revenue. A higher gross margin percentage indicates that the ICAD retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the ICAD's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the ICAD's total revenue generated. When comparing the revenue margin year over year, investors can gauge the ICAD's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the ICAD. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the ICAD's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

ICAD Margin History

ICAD Gross marginICAD Profit marginICAD EBIT marginICAD Profit margin
2026e85.37 %-9.08 %-8.69 %
2025e85.37 %-23.9 %-23.9 %
2024e85.37 %-37.26 %-37.3 %
202385.37 %-44.4 %-27.99 %
202270.9 %-49.86 %-48.89 %
202172.06 %-31.9 %-33.44 %
202071.89 %-31.62 %-59.29 %
201977.31 %-20.42 %-43.24 %
201875.84 %-31.73 %-35.21 %
201764.7 %-35.52 %-50.75 %
201670.31 %-37.85 %-38.34 %
201570.64 %-6.33 %-78.1 %
201471.11 %1.84 %-2.3 %
201369.82 %-5.38 %-23.01 %
201270.83 %-19.13 %-33.13 %
201169.91 %-50.44 %-131.2 %
201080.11 %-26.61 %-25.31 %
200977.59 %-7.54 %-7.01 %
200883.54 %12.72 %11.63 %
200780.23 %-4.17 %-6.05 %
200678.25 %-32.66 %-34.23 %
200576.53 %-24.03 %-24.68 %
200471.99 %-1.16 %-4.12 %

ICAD Stock Sales Revenue, EBIT, Earnings per Share

The ICAD earnings per share therefore indicates how much revenue ICAD has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue ICAD earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates ICAD's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of ICAD’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating ICAD's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

ICAD Revenue, EBIT and net profit per share

DateICAD Sales per ShareICAD EBIT per shareICAD Earnings per Share
2026e1.11 undefined0 undefined-0.1 undefined
2025e0.92 undefined0 undefined-0.22 undefined
2024e0.74 undefined0 undefined-0.28 undefined
20230.68 undefined-0.3 undefined-0.19 undefined
20221.11 undefined-0.55 undefined-0.54 undefined
20211.36 undefined-0.43 undefined-0.45 undefined
20201.34 undefined-0.42 undefined-0.8 undefined
20191.71 undefined-0.35 undefined-0.74 undefined
20181.54 undefined-0.49 undefined-0.54 undefined
20171.72 undefined-0.61 undefined-0.87 undefined
20161.65 undefined-0.63 undefined-0.63 undefined
20152.65 undefined-0.17 undefined-2.07 undefined
20143.11 undefined0.06 undefined-0.07 undefined
20133.05 undefined-0.16 undefined-0.7 undefined
20122.62 undefined-0.5 undefined-0.87 undefined
20112.63 undefined-1.32 undefined-3.45 undefined
20102.68 undefined-0.71 undefined-0.68 undefined
20093.09 undefined-0.23 undefined-0.22 undefined
20084.38 undefined0.56 undefined0.51 undefined
20073.47 undefined-0.14 undefined-0.21 undefined
20062.67 undefined-0.87 undefined-0.91 undefined
20052.7 undefined-0.65 undefined-0.67 undefined
20043.42 undefined-0.04 undefined-0.14 undefined

ICAD business model

ICAD Inc is a leading company in medical imaging and automated image processing. It was founded in 1984 and is headquartered in Nashua, New Hampshire, USA. ICAD is one of the most popular companies on Eulerpool.com.

ICAD SWOT Analysis

Strengths

ICAD Inc has a strong reputation in the industry and is known for its innovative products.

The company has a dedicated and skilled workforce, which contributes to its success.

ICAD Inc has a wide range of intellectual property rights and patents, providing a competitive advantage.

Weaknesses

ICAD Inc is heavily dependent on a few key clients, which poses a risk to its revenue stability.

The company has limited geographic reach, which limits its potential market and growth opportunities.

ICAD Inc faces challenges in terms of maintaining cost competitiveness compared to its larger competitors.

Opportunities

ICAD Inc can explore strategic partnerships or acquisitions to expand its market presence.

The growing demand for advanced technology solutions provides opportunities for ICAD Inc to develop new products.

The company can leverage its technology expertise to enter new industries and diversify its revenue streams.

Threats

ICAD Inc faces intense competition from both established players and emerging startups in the industry.

Economic downturns or market fluctuations can impact the company's sales and profitability.

Changes in regulations or policies may affect ICAD Inc's ability to operate or disrupt its supply chain.

ICAD Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

ICAD historical P/E ratio, EBIT, and P/S ratio.

ICAD shares outstanding

The number of shares was ICAD in 2023 — This indicates how many shares 25.613 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue ICAD earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates ICAD's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of ICAD’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating ICAD's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

ICAD Stock splits

In ICAD's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for ICAD.

ICAD latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.07 -0.06  (11.76 %)2024 Q2
3/31/2024-0.06 -0.05  (22.6 %)2024 Q1
12/31/2023-0.05 0.05  (191.91 %)2023 Q4
9/30/2023-0.09 -0.05  (45.53 %)2023 Q3
6/30/2023-0.11 -0.07  (37.61 %)2023 Q2
3/31/2023-0.12 -0.15  (-28.76 %)2023 Q1
12/31/2022-0.15 -0.12  (18.86 %)2022 Q4
9/30/2022-0.13 -0.15  (-13.12 %)2022 Q3
6/30/2022-0.11 -0.12  (-10.29 %)2022 Q2
3/31/2022-0.13 -0.14  (-9.8 %)2022 Q1
1
2
3
4
5
...
8

Eulerpool ESG Scorecard© for the ICAD stock

Eulerpool World ESG Rating (EESG©)

30/ 100

🌱 Environment

35

👫 Social

19

🏛️ Governance

37

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety❌
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

ICAD list of shareholders

%
Name
Stocks
Change
Date
4.64373 % Portolan Capital Management, L.L.C.1,232,445-12,20812/31/2023
4.51538 % Sassine (Andy H)1,198,382-40,0004/28/2023
4.09704 % The Vanguard Group, Inc.1,087,35531,51012/31/2023
2.56038 % First Eagle Investment Management, L.L.C.679,52518,68912/31/2023
2.55510 % Fidelity Management & Research Company LLC678,12401/31/2024
1.96756 % Renaissance Technologies LLC522,190182,38712/31/2023
1.60667 % Granahan Investment Management, LLC426,409-468,76012/31/2023
1.29691 % BlackRock Institutional Trust Company, N.A.344,201-63412/31/2023
1.28491 % PSM Vermögensverwaltung GmbH341,01602/29/2024
1.21584 % Greenwood Capital Associates, LLC322,685-2,63612/31/2023
1
2
3
4
5
...
10

ICAD Executives and Management Board

Mr. Jonathan Go60
ICAD Chief Technology Officer
Compensation 405,133
Mr. Andrew Sassine57
ICAD Independent Director
Compensation 163,512
Dr. Susan Wood59
ICAD Independent Director
Compensation 161,012
Dr. Rakesh Patel49
ICAD Independent Director
Compensation 152,012
Ms. Dana Brown58
ICAD Executive Chairman of the Board, President, Chief Executive Officer (since 2022)
Compensation 120,848
1
2

ICAD Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Siemens Stock
Siemens
SupplierCustomer0,780,300,470,810,170,08
Hologic Stock
Hologic
SupplierCustomer0,490,23-0,24-0,08-0,33-0,09
Carl Zeiss Meditec Stock
Carl Zeiss Meditec
SupplierCustomer0,480,250,620,830,670,08
Change Healthcare Stock
Change Healthcare
SupplierCustomer0,470,44-0,73-0,670,110,24
Koninklijke Philips Stock
Koninklijke Philips
SupplierCustomer0,170,200,520,800,900,85
FUJIFILM Holdings Stock
FUJIFILM Holdings
SupplierCustomer0,030,030,090,880,38-0,15
Canon Stock
Canon
SupplierCustomer-0,22-0,13-0,64-0,65-0,69-0,31
General Electric Stock
General Electric
SupplierCustomer-0,65-0,170,400,500,750,27
1

Most common questions regarding ICAD

What values and corporate philosophy does ICAD represent?

ICAD Inc represents values of innovation, collaboration, and dedication to advanced medical imaging technology. With a strong corporate philosophy focused on enhancing patient care and improving clinical outcomes, ICAD Inc continually develops cutting-edge solutions for early cancer detection and radiation therapy. By combining their expertise in artificial intelligence and image analysis, ICAD Inc enables healthcare professionals to make more accurate diagnoses and tailor personalized treatment plans. With a commitment to continuous improvement and providing superior healthcare solutions, ICAD Inc has established itself as a trusted leader in the industry.

In which countries and regions is ICAD primarily present?

ICAD Inc is primarily present in the United States, with headquarters located in Nashua, New Hampshire. As a leading provider of advanced image analysis technology solutions for the healthcare industry, ICAD Inc serves customers across the United States and also has a strong presence in Europe, Asia, and other regions around the globe. With its innovative solutions and commitment to improving patient outcomes, ICAD Inc continues to expand its reach in healthcare markets worldwide.

What significant milestones has the company ICAD achieved?

ICAD Inc has achieved several significant milestones over the years. Some of these include the development of innovative and leading-edge solutions for advanced imaging in the healthcare industry. The company has also successfully launched its renowned ProFound AI platform, which provides invaluable assistance to radiologists in the early detection of breast cancer. Furthermore, ICAD Inc has consistently focused on expanding its global presence by forging strategic partnerships and collaborations with industry leaders. With a commitment to continuous research and development, ICAD Inc continues to revolutionize the field of medical imaging, ensuring improved patient outcomes and enhanced clinical workflows.

What is the history and background of the company ICAD?

ICAD Inc is a renowned company that specializes in advanced image analysis and cancer detection technologies. With a rich history spanning several decades, ICAD Inc was founded in 1984 as a research and development firm focusing on computer-aided detection (CAD) tools for mammography. Over the years, the company expanded its portfolio, offering innovative solutions for various cancer types, including lung, colon, and prostate. With a commitment to improving patient outcomes, ICAD Inc remains at the forefront of cutting-edge medical advancements. Leveraging its expertise in artificial intelligence and machine learning, ICAD Inc continues to deliver state-of-the-art solutions for early cancer detection, contributing to the advancement of medical diagnostics.

Who are the main competitors of ICAD in the market?

The main competitors of ICAD Inc in the market include companies like Varian Medical Systems, Elekta AB, and Accuray Incorporated.

In which industries is ICAD primarily active?

ICAD Inc is primarily active in the healthcare and technology industries.

What is the business model of ICAD?

ICAD Inc's business model primarily focuses on providing innovative medical solutions to enhance cancer detection and therapy planning. As a leading provider of advanced imaging and radiation therapy technologies, ICAD aims to deliver state-of-the-art solutions that enable healthcare professionals to accurately diagnose and treat patients. Their expertise lies in developing and commercializing computer-aided detection (CAD) and workflow solutions for medical imaging in specialties such as breast, lung, and colon health. With a mission to improve patient outcomes and healthcare efficiency, ICAD Inc strives to revolutionize cancer care through their cutting-edge technologies.

What is the P/E ratio of ICAD 2024?

The ICAD P/E ratio is -4.98.

What is the P/S ratio of ICAD 2024?

The ICAD P/S ratio is 1.86.

What is the AlleAktien quality score of ICAD?

The AlleAktien quality score for ICAD is 3/10.

What is the revenue of ICAD 2024?

The expected ICAD revenue is 19.6 M USD.

How high is the profit of ICAD 2024?

The expected ICAD profit is -7.31 M USD.

What is the business model of ICAD

ICAD Inc is a US-based company that has been operating in the field of medical imaging since 1984. The company's business model focuses on the development and manufacturing of advanced imaging products. ICAD offers two main product lines: iCADx and ProFound AI. iCADx is a specialized group of diagnostic products used in image analysis in radiology and brachytherapy. ProFound AI is a groundbreaking software platform specifically designed for the interpretation of digital breast tomosynthesis (DBT). The two product lines from ICAD allow doctors to obtain more accurate and faster diagnostic results. The iCADx brand offers a range of products for the treatment of breast, prostate, lung, bone, and other types of cancer. The range also includes equipment for brachytherapy, a form of radiation therapy where a radiation source is directly inserted into the body. ProFound AI is an artificial intelligence (AI)-based software platform specifically designed for breast imaging. The system uses state-of-the-art algorithms and image analysis functions to assist the doctor in the early detection and diagnosis of breast cancer. In addition, ICAD also offers professional services such as training, customer support, and technical support. These services are aimed at ensuring that the products are used optimally and achieve the highest quality of imaging and diagnosis. ICAD also operates in the research and development field. The company continuously invests in research and development to improve and further develop its products, in order to provide medical users with the best possible diagnostics. The company also actively collaborates with leading medical institutions, research organizations, and other companies to drive collaborative projects and innovation in the field of medical imaging. In conclusion, it can be said that ICAD's business model is based on state-of-the-art medical imaging technology that improves diagnosis in medical practice. ICAD aims to drive further growth and expansion of the company by constantly improving its technologies and introducing innovative products to the market.

What is the ICAD dividend?

ICAD pays a dividend of 0 USD distributed over payouts per year.

How often does ICAD pay dividends?

The dividend cannot currently be calculated for ICAD or the company does not pay out a dividend.

What is the ICAD ISIN?

The ISIN of ICAD is US44934S2068.

What is the ICAD WKN?

The WKN of ICAD is A1J20J.

What is the ICAD ticker?

The ticker of ICAD is ICAD.

How much dividend does ICAD pay?

Over the past 12 months, ICAD paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ICAD is expected to pay a dividend of 0 USD.

What is the dividend yield of ICAD?

The current dividend yield of ICAD is .

When does ICAD pay dividends?

ICAD pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ICAD?

ICAD paid dividends every year for the past 0 years.

What is the dividend of ICAD?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ICAD located?

ICAD is assigned to the 'Health' sector.

Wann musste ich die Aktien von ICAD kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ICAD from 9/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did ICAD pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of ICAD in the year 2023?

In the year 2023, ICAD distributed 0 USD as dividends.

In which currency does ICAD pay out the dividend?

The dividends of ICAD are distributed in USD.

All fundamentals about ICAD

Our stock analysis for ICAD Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ICAD Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.